Alpha 2.0
Login Register
» Articles » PMID: 37450293

Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes

Overview
Journal JAMA
Publisher American Medical Association
Specialty General Medicine
Date 2023 Jul 14
PMID 37450293
Authors
Brian E McGarry
Benjamin D Sommers
Andrew D Wilcock
David C Grabowski
Michael L Barnett
Affiliations
Soon will be listed here.
Citing Articles

Measures to Prevent and Control COVID-19 in Skilled Nursing Facilities: A Scoping Review.

Canter B, Ulyte A, McGarry B, Barnett M JAMA Health Forum. 2025; 6(1):e245175.

PMID: 39888638 PMC: 11786235. DOI: 10.1001/jamahealthforum.2024.5175.

Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C).

Xiao X, Alexander G, Mehta H Pharmacoepidemiol Drug Saf. 2024; 33(8):e5869.

PMID: 39099263 PMC: 11309578. DOI: 10.1002/pds.5869.

Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults.

Penrose K, Srivastava A, Shen Y, Robertson M, Kulkarni S, Allen K Infect Dis Ther. 2024; 13(8):1743-1757.

PMID: 38909338 PMC: 11266331. DOI: 10.1007/s40121-024-01003-3.

Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes.

Dong S, Jutkowitz E, Giardina J, Bilinski A JAMA Health Forum. 2024; 5(4):e240688.

PMID: 38669030 PMC: 11065177. DOI: 10.1001/jamahealthforum.2024.0688.

Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System.

Appaneal H, LaPlante K, Lopes V, Martin C, Puzniak L, Wiemken T Infect Dis Ther. 2024; 13(1):155-172.

PMID: 38217842 PMC: 10828173. DOI: 10.1007/s40121-023-00910-1.